Edward Lewis Lain MD MBA

Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology

Fellow of American Academy of Dermatology. Chief Medical Officer, Sanova Dermatology Executive Director, Austin Institute for Clinical Research

Join to view full profile

5145 FM 620 NSte B-110Austin, TX 78732
Phone+1 512-266-0007
Fax+1 512-266-0077

Dr. Lain is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lain's full profile Already have an account?

Summary

Dr. Edward Lain is a dermatologist in Austin, TX. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in acne & rosacea, cosmetic dermatology, dermatologic surgery, and pediatric dermatology and is experienced in dermatologic surgery, cosmetic dermatology, pediatric dermatology, mohs micrographic surgery, and laser resurfacing/fractional laser resurfacing.

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 2003 - 2006
University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 2002 - 2003
Rice University Jesse H Jones Graduate School of ManagementMBA, Healthcare Administration, 2000 - 2002
Baylor College of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2005 - 2026
AR State Medical License 2004 - 2007
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
COMPLETED
PHASE2
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
COMPLETED
PHASE4
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
COMPLETED
PHASE2

Publications & Presentations

PubMed

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia
The Journal of Dermatological Treatment. 2026-12-01
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings.
Richard B Warren, Melinda Gooderham, Edward Lain, Robert Bissonnette, Yu-Huei Huang
Journal of the European Academy of Dermatology and Venereology. 2026-09-01
Rapid Results With TrenibotulinumtoxinE For the Treatment of Glabellar Lines in Toxin-naïve Adults: Safety, Efficacy, and Satisfaction Findings From a Pivotal Phase 3 ...
Edward Lain, Rosalyn George, Carmen Kavali, Terrence Keaney, Brenda LaTowksy
Aesthetic Surgery Journal. 2026-07-24

Lectures

Late-breaking Research: Clinical Trials
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual MeetingMarch 4th, 2019
Galderma Announces Positive Results from the “CoMMPlete” Regimen Study Including Epiduo® Gel in the Management of Acne in Adolescent Student AthletesMay 24th, 2016